Erik Larsen

Mr. Larsen has over 20 years of experience in healthcare investing, investment banking and corporate development.

Prior to joining Concord, Mr. Larsen served as Vice President, Corporate Development for the Special Assets Group at HCA Healthcare, Inc. (NYSE: HCA), one of the leading healthcare providers in the US, operating 186 hospitals and ~2,000 sites of care across the United States and United Kingdom. At HCA Healthcare, Mr. Larsen led the Special Assets Group, including leadership of the Company’s corporate venture group (dba Health Insight Capital) from 2017 to 2022. Prior to joining HCA Healthcare in 2011, Mr. Larsen was a Director of Development at Renal Advantage, a private-equity backed outpatient dialysis provider and an investment banking professional at Morgan Joseph & Co and VelocityHealth Capital, Inc.

Mr. Larsen received a B.A. from Wake Forest University, and an MBA from Wake Forest University, Babcock Graduate School of Management.